Rabepine-DSR is a dual-action medication designed to provide effective relief from gastroesophageal reflux disease (GERD) and associated acidity. Combining a proton pump inhibitor (PPI) and a prokinetic agent, it reduces stomach acid production and improves gastric motility, ensuring long-lasting comfort and digestive health.
₹ 95
Test | Specifications | Results |
---|---|---|
Description | Clear & orange colour, hard gelatin capsule shell containing orange & brick red pellets. | Clear & orange colour, hard gelatin capsule shell containing orange & brick red pellets. |
Identification | Should be comply as per assay test | Complies |
Average weight of capsule | 340.0 mg ± 7.5% (314.5 mg to 365.5 mg) | 340.5 mg |
Average filled wt. of Capsule | 280.0 mg ± 10% (252.0 mg to 308.0 mg) | 275.8 mg |
Uniformity of wt. | Average weight ± 10% | Max +3.33% Min -1.74% |
Dissolution Test for (Dompcridone) For I st hour |
Between (15% to 50%) | Min -21.5% Max - 33.2% |
Dissolution Test for (Dompcridone) For 4th hour |
Between (30% to 70%) | Min -35.5% Max - 55.6% |
Dissolution Test for (Dompcridone) For 8th hour |
Between (55% to 90%) | Min -64.6% Max - 77.5% |
Dissolution Test for (Dompcridone) For 12th hour |
Between (NLT 70%) | Min -73.3% Max - 86.4% |
Dissolution Test for (Rabeprazole) In Acid Medium |
(NMT 10%) | Min -2.0% Max - 6.2% |
Dissolution Test for (Rabeprazole) In Buffer Medium |
(NLT 70%) | Min -75.6% Max - 91.4% |
Assay (Each hard gelatin capsule contains)-Rabeprazole
Sodium (As enteric coated pellets) IP 20 mg |
18.0 mg to 22.0 mg & 90% to 110% | 20.603 mg & 103.02% |
Assay (Each hard gelatin capsule
contains)-Domperidone (As sustained release pellets) IP 30 mg |
27.0 mg to 33.0 mg & 90% to 110% | 30.287 mg & 100.96% |